![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » RANBAXY TO SUPPLY GENERIC DRUG IN CANADA
RANBAXY TO SUPPLY GENERIC DRUG IN CANADA
Ranbaxy Laboratories Limited's wholly owned subsidiary, Ranbaxy Pharmaceuticals Canada Inc. (RPCI) and Janssen-Ortho Inc. (JOI), have entered into a licensing and supply agreement for a generic version of risperidone compressed tablets, sold under Ranbaxy's label, Ran Risperidone. Ranbaxy is the first Indian company to market a licensed generic product in Canada.
BioSpectrum (http://www.biospectrumasia.com/content/200706IND1182.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct